Dr CS Pramesh, Director of Tata Memorial Hospital and Professor and Head of Thoracic Surgery at Tata Memorial Centre in Mumbai, India, has been elected President-elect of the Union for International Cancer Control (UICC) for the 2026–2028 term.
The election took place during the UICC General Assembly on October 20, 2026, alongside the appointment of the organisation’s new Board of Directors.
Dr Pramesh is a surgical oncologist, researcher, and health systems leader internationally recognised for his contributions to improving access, quality, and equity in cancer care, particularly in low- and middle-income countries.
He currently serves at Tata Memorial Centre, one of the world’s largest comprehensive cancer centres, where his work encompasses clinical oncology, research, and initiatives aimed at strengthening cancer care delivery.
Following his election, Dr Pramesh expressed his commitment to the organisation’s mission:
“I accept the responsibility with a lot of humility, enthusiasm and a deep sense of commitment. I am confident that together, we can make a real difference for people affected by cancer everywhere.”
— Dr CS Pramesh, UICC President-elect
A New Board to Guide UICC’s Global Mission
Alongside the election of Dr Pramesh, UICC members elected the new Board of Directors for the 2026–2028 term.
The Board represents UICC’s global membership of more than 1,100 organisations across over 170 countries and territories. Working alongside the President and President-elect, its members will provide strategic oversight and guide the organisation’s efforts to strengthen international collaboration and advance equitable cancer control.
Cary Adams, CEO of UICC, congratulated the newly elected leadership:
“I extend my warm welcome and congratulations to our new President, President-elect and Board members. Their collective experience, perspectives and dedication will be invaluable as UICC continues its mission to unite and support the cancer community and drive progress towards more equitable cancer control worldwide.”
— Cary Adams, CEO, UICC
The newly elected leadership will serve during the 2026–2028 term, supporting UICC’s continued work to unite cancer organisations, strengthen global cooperation, and improve cancer outcomes worldwide.
Stay informed with more articles like this on OncoDaily.
